Gravita Diagnostyka I Leczenie Nieplodnosci

Ul. Gen. Karola Kniaziewicza 20a, Lodz, 91-347, Poland

Immune System Processes

At Gravita Diagnostyka I Leczenie Nieplodności, researchers are investigating how the body’s immune defenses can be harnessed to prevent serious viral diseases. Current work includes evaluating the protective effect of a monoclonal antibody against respiratory syncytial virus (RSV) in young children, and studying the immune response generated by a 9‑valent human papillomavirus (HPV) vaccine administered with varied dosing schedules to adolescents. The overarching goal is to confirm safety, tolerability, and strong immunogenicity of these preventive strategies.

Assessment of RSV prophylaxis in infants
Optimization of HPV vaccine dosing for pre‑teens and teens
Comprehensive safety monitoring of investigational vaccines

The Łódź‑based site has launched two clinical studies, involving three investigators, to advance vaccine science and improve public health outcomes.

#1 Clinical Trials Search in Europe

Gravita Diagnostyka I Leczenie Nieplodnosci

Immune System Processes

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Study on the Safety and Immune Response of 9vHPV Vaccine in Preventing HPV in Boys and Girls Aged 9-14 Compared to Young Women Aged 16-26

Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

Study on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease

Gravita Diagnostyka I Leczenie Nieplodnosci

Immune System Processes

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Study on the Safety and Immune Response of 9vHPV Vaccine in Preventing HPV in Boys and Girls Aged 9-14 Compared to Young Women Aged 16-26

Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

Study on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease

We use cookies